129 related articles for article (PubMed ID: 22650645)
1. Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Boas-Knoop S; Yahyazadeh A; Neuhaus R; Somasundaram R; Ruehl M; Puhl G; Neuhaus P; Neumann UP; Bahra M
Transpl Infect Dis; 2012 Oct; 14(5):488-95. PubMed ID: 22650645
[TBL] [Abstract][Full Text] [Related]
2. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma.
Eurich D; Boas-Knoop S; Morawietz L; Neuhaus R; Somasundaram R; Ruehl M; Neumann UP; Neuhaus P; Bahra M; Seehofer D
Liver Int; 2011 Aug; 31(7):1006-12. PubMed ID: 21733090
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
4. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of STAT-4 affect the development of graft fibrosis after liver transplantation for HCV-induced liver disease.
Eurich D; Boas-Knoop S; Struecker B; Neuhaus R; Neuhaus P; Bahra M
Transplantation; 2013 Jan; 95(1):203-8. PubMed ID: 23202532
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
[TBL] [Abstract][Full Text] [Related]
7. Mannose binding lectin (+54) exon 1 gene polymorphism in Tunisian kidney transplant patients.
Gorgi Y; Sfar I; Aouadi H; Makhlouf M; Abderrahim E; Jendoubiayed S; Bardi R; Ben Abdallah T; Ayed K
Transplant Proc; 2009 Mar; 41(2):660-2. PubMed ID: 19328949
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D; Wójtowicz A; Bibert S; Pyndiah N; Manuel O; Binet I; Buhler LH; Huynh-Do U; Mueller T; Steiger J; Pascual M; Meylan P; Bochud PY;
Kidney Int; 2016 Apr; 89(4):927-38. PubMed ID: 26924055
[TBL] [Abstract][Full Text] [Related]
9. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
10. Association of hepatitis C virus infection and liver fibrosis severity with the variants alleles of MBL2 gene in a Brazilian population.
Halla MC; do Carmo RF; Silva Vasconcelos LR; Pereira LB; Moura P; de Siqueira ER; Pereira LM; Mendonça Cavalcanti Mdo S
Hum Immunol; 2010 Sep; 71(9):883-7. PubMed ID: 20570631
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
13. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
Bitetto D; Fabris C; Falleti E; Fornasiere E; Avellini C; Cmet S; Cussigh A; Fontanini E; Pirisi M; Corradini SG; Merli M; Molinaro A; Toniutto P
Transplantation; 2012 May; 93(10):1038-44. PubMed ID: 22495472
[TBL] [Abstract][Full Text] [Related]
14. Mannose-binding lectin gene polymorphisms are not associated with susceptibility to hepatitis C virus infection in the Brazilian Amazon region.
Vallinoto AC; da Silva RF; Hermes RB; Amaral IS; Miranda EC; Barbosa MS; Moia Lde J; Conde SR; Soares Mdo C; Lemos JA; Machado LF; Ishak MO; Ishak R
Hum Immunol; 2009 Sep; 70(9):754-7. PubMed ID: 19540295
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
16. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
17. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
[TBL] [Abstract][Full Text] [Related]
18. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
20. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation.
Worthley DL; Johnson DF; Eisen DP; Dean MM; Heatley SL; Tung JP; Scott J; Padbury RT; Harley HA; Bardy PG; Angus PW; Mullighan CG
Clin Infect Dis; 2009 Feb; 48(4):410-7. PubMed ID: 19143554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
